Evoke Pharma (EVOK) Reports In-Line Q1 EPS

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.55), in-line with the analyst estimate of ($0.55).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Ennis (EBF) Misses Q2 EPS by 2c
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals